Yamamoto, Y.; Otsuka, Y.; Tokumasu, K.; Sunada, N.; Nakano, Y.; Honda, H.; Sakurada, Y.; Hasegawa, T.; Hagiya, H.; Otsuka, F.
Utility of Serum Ferritin for Predicting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Patients with Long COVID. J. Clin. Med. 2023, 12, 4737.
https://doi.org/10.3390/jcm12144737
AMA Style
Yamamoto Y, Otsuka Y, Tokumasu K, Sunada N, Nakano Y, Honda H, Sakurada Y, Hasegawa T, Hagiya H, Otsuka F.
Utility of Serum Ferritin for Predicting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Patients with Long COVID. Journal of Clinical Medicine. 2023; 12(14):4737.
https://doi.org/10.3390/jcm12144737
Chicago/Turabian Style
Yamamoto, Yukichika, Yuki Otsuka, Kazuki Tokumasu, Naruhiko Sunada, Yasuhiro Nakano, Hiroyuki Honda, Yasue Sakurada, Toru Hasegawa, Hideharu Hagiya, and Fumio Otsuka.
2023. "Utility of Serum Ferritin for Predicting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Patients with Long COVID" Journal of Clinical Medicine 12, no. 14: 4737.
https://doi.org/10.3390/jcm12144737
APA Style
Yamamoto, Y., Otsuka, Y., Tokumasu, K., Sunada, N., Nakano, Y., Honda, H., Sakurada, Y., Hasegawa, T., Hagiya, H., & Otsuka, F.
(2023). Utility of Serum Ferritin for Predicting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Patients with Long COVID. Journal of Clinical Medicine, 12(14), 4737.
https://doi.org/10.3390/jcm12144737